Avenue Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Other Revenue	1.4	-	-	-	-	Upgrade
Revenue	1.4	-	-	-	-	Upgrade
Gross Profit	1.4	-	-	-	-	Upgrade
Selling, General & Admin	3.65	4.64	4.18	5.35	2.48	Upgrade
Research & Development	1.04	6.65	10.36	2.7	1.25	Upgrade
Operating Expenses	4.69	11.28	14.54	8.04	3.74	Upgrade
Operating Income	-3.29	-11.28	-14.54	-8.04	-3.74	Upgrade
Interest & Investment Income	0.12	0.18	0.13	0.02	0.01	Upgrade
Other Non Operating Income (Expenses)	0.02	-0.59	3.93	4.42	-	Upgrade
EBT Excluding Unusual Items	-3.15	-11.7	-10.49	-3.6	-3.73	Upgrade
Gain (Loss) on Sale of Assets	0.2	-	-	-	-	Upgrade
Pretax Income	-2.95	-11.7	-10.49	-3.6	-3.73	Upgrade
Earnings From Continuing Operations	-2.95	-11.7	-10.49	-3.6	-3.73	Upgrade
Minority Interest in Earnings	0.04	0.04	0.11	0.05	-	Upgrade
Net Income	-2.91	-11.65	-10.38	-3.55	-3.73	Upgrade
Net Income to Common	-2.91	-11.65	-10.38	-3.55	-3.73	Upgrade
Shares Outstanding (Basic)	3	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	3	1	0	0	0	Upgrade
Shares Change (YoY)	141.75%	817.14%	384.72%	92.83%	2.98%	Upgrade
EPS (Basic)	-0.93	-9.00	-73.48	-121.92	-246.94	Upgrade
EPS (Diluted)	-0.93	-9.00	-73.48	-121.92	-246.94	Upgrade
Gross Margin	100.00%	-	-	-	-	Upgrade
Operating Margin	-234.05%	-	-	-	-	Upgrade
Profit Margin	-207.19%	-	-	-	-	Upgrade
EBIT	-3.29	-11.28	-14.54	-8.04	-3.74	Upgrade
EBIT Margin	-234.05%	-	-	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.